CanWell Pharma will present the latest research developments at the 39th of The Society for Immunotherapy of Cancer (SITC) Annual Meeting held on Nov6-10, 2024 in Houston, TX. The research developments are from its two different studies and will be conducted on the following two posters:

Date: Nov8, 2024

Location: Exhibit Halls A B George R. Brown Convention Center

Poster 1 (No. 689)

Results From A Phase I Dose Escalation Trial of CAN1012 in Patients With Solid Tumors

Poster 2 (No. 1345)

CAN2109: Preclinical Development of A Novel Long-Acting Immunogenic Cell Death (ICD) Inducer for Cancer Therapy